Pharmaceutical Information - August 8, 2008

Wal-Mart Brings Down Drug Prices With $10 Plan

May 5, 2008 - Topics senior, prescription, breast cancer, cancer and women
Wal-Mart rolled out on Monday its 90-day special offer to American consumers that sells medicine for $10. The promo includes marked down prices for women's medication and more price cuts on over 1,000 over-the-counter pharmaceuticals.

The $10 drugs cover 350 generic medicines for 90-day prescriptions at Wal-Mart, Neighborhood Market and Sam's Club drugstores across the U.S., except in North Dakota where Wal-Mart has no in-store drugstores. The women's drugs, including treatments for breast cancer and hormone deficiency, are sold at $9. Meanwhile, prices for over 1,000 over-the-counter medication are lowered to $4 or less

read more >>

Federal Agency Approves Use Of Generic Wellbutrin In Depression Patients

April 16, 2008 - Topics wellbutrin, depression, bupropion, pharmaceutical and fda
The U.S. Food and Drug Administration said Wednesday that a generic version of a popular name brand antidepressant is both safe and effective, despite recent consumer complaints

The federal agency reviewed the generic version of Wellbutrin manufactured by Teva after some patients reported their depression returned when they switched from the brand name drug Wellbutrin XL to the generic pharmaceutical. Some patients also complained of headaches, anxiety and other side effects

read more >>

Study Alleges Merck Downplayed Death Risk Of Vioxx

April 15, 2008 - Topics vioxx, study, disease, heart disease and stroke
Drug giant Merck and Co. manipulated data on its withdrawn drug Vioxx, minimized a significantly increased risk of death in patients taking its painkiller and used academic researchers to enhance the credibility of scientific studies largely written by Merck employees.

The allegations come from new research published in the Journal of the American Medical Association. The magazine said Merck offered to pay doctors to sign their names to Vioxx studies ghostwritten by medical publishing companies even if the physicians had little or no involvement in the research

read more >>

Blood Test To Detect Alzheimer's Set For Launch In U.S.

April 7, 2008 - Topics blood, pharmaceutical and disease
A blood test that offers patients an early diagnosis of Parkinson's and Alzheimer's could be available by the end of the year in the U.S. market.

Power 3 Medical Products, an Oklahoma-based pharmaceutical company, says it plans to bring the test, called NuroPro, to market by the third quarter or fourth quarter of this year

read more >>

Study: Free Drug Samples Cause Bigger Bills In The Long Run

March 26, 2008 - Topics study, prescription, pharmaceutical and medicine
A new study reveals that a medical practice which is meant to save patients money may end up costing them more in the long run. Patients who receive free samples of prescription drugs mostly end up spending more on prescription medication than those who don't.

Study author Dr. Caleb Alexander says that pharmaceutical companies give free samples for the new drugs they are selling. He added that these medicines, while helping patients' wallets in the short term, will be continued in a longer term and the patients may use newer more costly medicines than their older and less expensive alternative

read more >>





© Copyright 2008 Webmedia Publishing, SA - all rights reserved.     Contact Us  |  Privacy Policy  |  Disclaimer  |  Terms of Use